Arteris, Inc. (NASDAQ:AIP - Free Report) - Equities researchers at Northland Capmk issued their Q1 2026 earnings per share (EPS) estimates for Arteris in a research note issued to investors on Wednesday, February 19th. Northland Capmk analyst G. Richard forecasts that the company will earn ($0.14) per share for the quarter. The consensus estimate for Arteris' current full-year earnings is ($0.71) per share. Northland Capmk also issued estimates for Arteris' Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.10) EPS and Q4 2026 earnings at ($0.07) EPS.
A number of other research firms also recently issued reports on AIP. Northland Securities boosted their target price on shares of Arteris from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Wednesday. Rosenblatt Securities reiterated a "buy" rating and set a $15.00 price objective on shares of Arteris in a report on Tuesday.
Check Out Our Latest Stock Report on AIP
Arteris Price Performance
Shares of AIP opened at $9.85 on Friday. Arteris has a 52-week low of $5.76 and a 52-week high of $12.64. The business's 50 day moving average price is $10.55 and its two-hundred day moving average price is $8.71. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.17 and a quick ratio of 1.16.
Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.08). Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. The business had revenue of $15.49 million during the quarter, compared to analyst estimates of $15.34 million.
Insider Buying and Selling
In other news, Director Saiyed Atiq Raza sold 12,166 shares of the stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $10.07, for a total value of $122,511.62. Following the completion of the sale, the director now directly owns 731,560 shares of the company's stock, valued at $7,366,809.20. This represents a 1.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Nicholas B. Hawkins sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $8.56, for a total value of $42,800.00. Following the completion of the transaction, the chief financial officer now owns 190,414 shares in the company, valued at $1,629,943.84. This represents a 2.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 367,157 shares of company stock worth $3,828,388 in the last ninety days. Corporate insiders own 33.70% of the company's stock.
Institutional Investors Weigh In On Arteris
Institutional investors and hedge funds have recently bought and sold shares of the stock. US Bancorp DE bought a new stake in shares of Arteris in the 3rd quarter worth $34,000. Quarry LP purchased a new position in Arteris during the fourth quarter worth about $46,000. R Squared Ltd bought a new stake in Arteris in the 4th quarter worth about $64,000. D. E. Shaw & Co. Inc. bought a new stake in Arteris in the 4th quarter worth about $110,000. Finally, Price T Rowe Associates Inc. MD purchased a new stake in Arteris in the 4th quarter valued at about $117,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
